NA Type of group

LINEZOLID (PNU 100766) IN THE TREATMENT OF PNEUMONIA BY ESTREPTOCOCO PNEUMONIAE. A DOUBLE BLIND ASSESSMENT STUDYING THE INTRAVENOUS ADMINISTRATION OF LINEZOLID WITH ORAL CONTINUATION COMPARED TO THE INTRAVENOUS ADMINISTRATION OF SODIUM CEFTRIAXONE FOLLOWED BY THE ORAL ADMINISTRATION OF PROXETIL CEFPODOXYM.

LINEZOLID VS. CLARITHROMYCIN IN THE TREATMENT OF UNCOMPLICATED INFECTIONS OF SKIN AND SOFT FABRICS

ORAL LINEZOLID IN THE TREATMENT OF EXTRAHOSPITAL PNEUMONIA IN AMBULATORY PATIENTS

TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C USING ALFA 2B INTERFERON ASSOCIATED WITH RIBAVIRINE, COMPARING IT WITH THE SAME SCHEME PREVIOUS FROM DAILY ADMINISTRATION FOR 2 WEEKS OF ALFA 2 B INTERFERON

MELAVIRDINE MESYLATE: PHARMACOCINETIC, RANDOMIZED COMPARISON, OF PARALLEL GROUPS AND OPEN MARBETE OF SQV + 3TC + AZT + DLV TWO OR THREE DAILY TIMES VS SQV + 3TC + AZT + DLV IN THE TREATMENT OF HIV POSITIVE PATIENTS

A DOUBLE BLIND, RANDOMIZED, STRATIFIED STUDY IN PARALLEL GROUPS TO EVALUATE THE INCIDENCE OF ULCERA, BLEEDING OR PERFORATIONS DURING CHRONIC TREATMENT WITH MI-0966 OR NAPROXENE IN PATIENTS WITH REUMATOID ARTHRITIS, INTERNATIONAL COHORT

52 WEEKS STUDY, WITH ACTIVE AND CONTROLLED COMPARATOR WITH PLACEBO, PARALLEL GROUPS, DOUBLE BLIND, RANDOMIZED TO ASSESS THE SAFETY AND EFFECTIVENESS OF THE DAILY DOSE OF 25 AND 50 MG OF MK-966 IN PATIENTS WITH Rheumatoid ARTHRITIS (PART I)

IN VITRO SUSCEPTIBILITY OF MOXIFLOXACIN OF THE MOST COMMON PATHOGENS OF THE RESPIRATORY SYSTEM REGIONAL STUDY IN LATIN AMERICA

COMPARATIVE STUDY, DOUBLE BLIND, RANDOMIZED, PROSPECTIVE, MULTICENTRIC TO EVALUATE THE SAFETY, LOCAL TOLERABILITY AND CLINICAL RESULTS OF SODIUM ERTAPENEM (MK-0826) AGAINST SODIUM CEFTRIAXONE PATIENT INFLUENCED PEDIAT INFECTED PEDIAT INFLUENCED PEDIAT INFLUENCED PEDIAT INFLUENCED PEDIAT INFLATED PEDIAT INFECTION OR COMMUNITY ACQUIRED PNEUMONIA